Centrus Energy Corp. (NYSE:LEU) is trending after the company announced a multi-year contract with Radiant to supply high-assay, low-enriched uranium for the Kaleidos microreactor fleet.
- Centrus stock is showing downward pressure. Where is LEU stock headed?
Centrus, Radiant Sign HALEU Supply Deal
Under the agreement, Centrus will begin delivering HALEU before the end of the decade, adding another domestic fuel source to support commercial scale-up of Radiant’s Kaleidos microreactors. The deal includes prepayments from Radiant to Centrus to support its domestic commercial enrichment capacity program. Because Centrus’ technology is U.S.-origin and relies on a U.S. manufacturing supply chain, the enrichment provided to Radiant will be “unobligated,” meaning it can be used for national security applications — a capability Centrus says is unique among deployment-ready U.S.-origin enrichment technologies today, through its AC100 centrifuge design.
“The contract with Radiant marks another important step in building the domestic fuel supply chain needed to support the next generation of nuclear energy,” said Amir Vexler, President and CEO of Centrus. “By expanding our work to include innovative microreactor developers like Radiant, we are strengthening the U.S.-based fuel supply network.”
“You can’t deploy nuclear reactors without fuel, so we have approached our fuel supply the same way we have approached the reactor: build it in parallel, and don’t depend on any single path,” said Dr. Rita Baranwal, Chief Nuclear Officer of Radiant. “This agreement gives Kaleidos a continued source of HALEU for commercial and national security applications and removes one of the biggest constraints facing advanced nuclear deployment.”
Centrus Shares Trade Flat
LEU Price Action: At the time of publication, Centrus shares are trading 0.69% lower at $184.25, according to data from Benzinga Pro.
This illustration was generated using artificial intelligence via Midjourney.
